Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Current Leases: 2023-2024

Historic Current Leases for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Dec 2024 value amounting to $3.7 million.

  • Monte Rosa Therapeutics' Current Leases rose 16.32% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 16.32%. This contributed to the annual value of $3.7 million for FY2024, which is 17.46% up from last year.
  • As of FY2024, Monte Rosa Therapeutics' Current Leases stood at $3.7 million, which was up 17.46% from $3.2 million recorded in FY2023.
  • In the past 5 years, Monte Rosa Therapeutics' Current Leases registered a high of $3.7 million during FY2024, and its lowest value of $3.2 million during FY2023.
  • Its 2-year average for Current Leases is $3.4 million, with a median of $3.4 million in 2023.
  • Data for Monte Rosa Therapeutics' Current Leases shows a peak YoY rose of 17.46% (in 2024) over the last 5 years.
  • Monte Rosa Therapeutics' Current Leases (Yearly) stood at $3.2 million in 2023, then grew by 17.46% to $3.7 million in 2024.